Stent malapposition and the risk of stent thrombosis: Mechanistic insights from an in vitro model

Nicolas Foin, Shengjie Lu, Jaryl Ng, Heerajnarain Bulluck, Derek J. Hausenloy, Philip E. Wong, Renu Virmani, Michael Joner

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Abstract

Aims: The aim of this report was to examine the effect of underexpansion on stent thrombogenicity with an in vitro perfusion model. Methods and results: Drug-eluting stent (DES) samples were partially underdeployed in silicone tubes and perfused with porcine blood containing 10% anticoagulant citrate dextrose solution for four minutes at a flow rate of 200 ml/min. Thrombus formation was evaluated and compared between the well-apposed and malapposed sections. The malapposed sections showed significantly more thrombus formation compared to the well-apposed sections (13.9 vs. 0.41 mm2, p<0.001). Conclusions: Stent malapposition has a very direct impact on thrombus formation. Optimised stent implantation is required to minimise malapposition in DES and BVS to reduce thrombus formation.

Original languageEnglish
Pages (from-to)e1096-e1098
JournalEuroIntervention
Volume13
Issue number9
DOIs
StatePublished - Oct 2017

Keywords

  • Drug-eluting stent
  • Optical coherence tomography
  • Stent thrombosis

Fingerprint

Dive into the research topics of 'Stent malapposition and the risk of stent thrombosis: Mechanistic insights from an in vitro model'. Together they form a unique fingerprint.

Cite this